- Home
- SNDL vs PRQR Comparison
SNDL vs PRQR Comparison
Compare SNDL & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNDL | PRQR |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | Canada | Netherlands |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 312.4M | 262.5M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SNDL | PRQR |
|---|---|---|
| Price | $1.42 | $2.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $5.00 | ★ $7.25 |
| AVG Volume (30 Days) | ★ 1.4M | 925.0K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.19 | N/A |
| Revenue Next Year | $3.08 | $13.92 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.17 | $1.33 |
| 52 Week High | $2.89 | $3.10 |
Technical Indicators
Market Signals| Indicator | SNDL | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 66.36 | 53.63 |
| Support Level | $1.34 | $1.40 |
| Resistance Level | $1.49 | $2.25 |
| Average True Range (ATR) | 0.05 | 0.15 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 100.00 | 42.11 |
Price Performance
Historical ComparisonAbout SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.